Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
2
Pebblebed, Refactor Capital
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
Tractionpublic signals, read monthly
Web presence
top 2%
of 133.2M domains by links, Common Crawl
Hacker News stories
4
best: 2 points
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Reticular51-200 employees
Reticular is a reproductive-genetics information service for people planning a pregnancy or using IVF.
GeneticoVenture round $2.8M · 2 yr ago • Founded 2012 • 11-50 employees • 3 roles
Genetico is a Russian centre for genetics and reproductive medicine offering genetic testing. Patients can take genetic tests and consult a…
Feanix Autopilot combines whole-genome sequencing, DairyComp, EZfeed, milk checks, feed costs, health records, and real farm performance…
InocrasSeries B $31M · 2 mo ago • Founded 2020 • 51-200 employees
Unlock the potential of a Whole Genome Sequencing Test with Inocras. Transforming diagnosis and treatment for cancer and rare diseases.
MyOme1 role
MyOme is a clinical whole genome analysis platform company helping families understand their risk for inherited diseases. As a leader in…
Our most in-depth DNA analysis. DNA Complete by Nebula Genomics analyzes 100% of your genome—unlike typical tests that read less than 1%…

Overview

Screen embryos for 400+ genetic conditions before pregnancy. Orchid's whole genome screening reads 99% of an embryo's genome — 100x more data than standard PGT.

News

News WIRED 1 year ago
Whole-Genome Sequencing Will Change Pregnancy
At WIRED Health 2025, Orchid CEO Noor Siddiqui and genomics pioneer George Church laid out their view of the future of genetic screening.
Read more
Report
News orchidhealth.com 1 year ago
Polygenic embryo screening and your family
Introducing our Polygenic Risk Calculator, to help families understand the risk reduction that embryo prioritization can achieve for common chronic diseases
Read more
Report
News The New Yorker 1 year ago
How Much Should You Know About Your Child Before He's Born?
Jessica Winter on a new book about navigating the stratified landscape of contemporary reproductive technology.
Read more
Report
News orchidhealth.com 1 year ago
Meet Orchid, the first whole genome embryo reports
Orchid's whole genome embryo reports are now available at IVF centers nationwide
Read more
Report
News GQ 1 year ago
Meet the People Fighting the
One man journeys through the many movements-sci-fi startups, DIY donor clubs, group masturbation retreats-urgently attempting to address the impending spermpocalypse.
Read more
Report
News BostonGlobe.com 2 years ago
Would you do it if you could? Advanced DNA testing for embryos is here - and it's fraught. - The Boston Globe
We're still far from "Brave New World" or "Gattaca" but also closer than you may think.
Read more
Report
News Freethink 3 years ago
Startup can now screen IVF embryos for 1000+ diseases
Startup Orchid now offers whole genome sequencing for embryos used during IVF - but not everyone is convinced it's worth the cost.
Read more
Report
News Business Insider 3 years ago
Orchid tests embryos for genetic diseases. It just raised $12 million with this 11-slide pitch deck.
The San Francisco-based startup raised the funds in a round led by Prometheus Fund with additional backing from high-profile angels, including Figma CEO Dylan Field.
Read more
Report
News CNBC 3 years ago
Reproductive startup launches test to identify an embryo's genetic defects before an IVF pregnancy begins
Orchid announces world's first whole genome sequencing report for embryos.
Read more
Report
Show more news